Moleculin Biotech, Inc. (MBRX)

4.51 +0.25 (+5.87%) USD  |  NASDAQ  |  Jan 21, 11:27
More

Moleculin Biotech Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for MBRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. Upgrade
Harvard Bioscience, Inc. Upgrade
Intensity Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade